CA

Chellayyan Asari Madhavi Surendran

Active Director Director DIN 11307858
DIN 11307858 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chellayyan Asari Madhavi Surendran

Data last updated:

Chellayyan Asari Madhavi Surendran is a Director at Macways Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11307858
Primary Designation Director
Industry Pharma
First Appointment 19 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Sep 20252025Active

Board colleagues of Chellayyan Asari Madhavi Surendran

Directorship timeline

Open interactive timeline →
Macways Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chellayyan Asari Madhavi Surendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chellayyan Asari Madhavi Surendran

Chellayyan Asari Madhavi Surendran currently holds 1 directorship: Macways Pharmaceuticals Private Limited (Director, since 19 Sep 2025).

Chellayyan Asari Madhavi Surendran was first appointed on 19 Sep 2025 as Director at Macways Pharmaceuticals Private Limited.

The current boards of Chellayyan Asari Madhavi Surendran's companies include Soumya Kumbalamkeril Shaji (Macways Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available